FDA Approved Products
4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
LATISSE
bimatoprost
LOE Approaching
AbbVie
TOPICAL · SOLUTION/DROPS
hypotrichosis of the eyelashes by increasing their growth including lengththickness+1
2008
NDA30/100
LERITINE
anileridine hydrochloride
LOE Approaching
Merck & Co.
ORAL · TABLET
1957
NDA30/100
LESCOL
fluvastatin sodium
LOE Approaching
Novartis
ORAL · CAPSULE
1993
NDA30/100
LESCOL XL
fluvastatin sodium
LOE Approaching
Novartis
ORAL · TABLET, EXTENDED RELEASE
2000
NDA30/100
LEUCOVORIN CALCIUM
leucovorin calcium
LOE Approaching
ORAL · TABLET
1980
NDA30/100
LEUCOVORIN CALCIUM
leucovorin calcium
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1952
NDA30/100
LEUKERAN
chlorambucil
LOE Approaching
Viatris (2)
ORAL · TABLET
1957
NDA30/100
LEUSTATIN
cladribine
LOE Approaching
Johnson & Johnson
INJECTION · INJECTABLE
1993
NDA30/100
LEVAQUIN
levofloxacin
LOE Approaching
Johnson & Johnson
ORAL · TABLET
1996
SMNDA30/100
LEVAQUIN
levofloxacin
LOE Approaching
Johnson & Johnson
INJECTION · INJECTABLE
1996
SMNDA30/100
LEVAQUIN
levofloxacin
LOE Approaching
Johnson & Johnson
ORAL · SOLUTION
2004
SMNDA30/100
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
levofloxacin
LOE Approaching
Johnson & Johnson
INJECTION · INJECTABLE
1996
SMNDA30/100
LEVATOL
penbutolol sulfate
LOE Approaching
ORAL · TABLET
1987
NDA30/100
LEVLITE
ethinyl estradiol; levonorgestrel
LOE Approaching
Bayer
ORAL-28 · TABLET
1998
NDA30/100
LEVO-DROMORAN
levorphanol tartrate
LOE Approaching
Bausch + Lomb
ORAL · TABLET
1953
NDA30/100
LEVO-DROMORAN
levorphanol tartrate
LOE Approaching
Bausch + Lomb
INJECTION · INJECTABLE
1953
NDA30/100
LEVO-T
levothyroxine sodium
LOE Approaching
ORAL · TABLET
hypothyroidism during the recovery phase of subacute thyroiditis
2002
NDA30/100
LEVONORGESTREL
levonorgestrel
LOE Approaching
Pfizer
IMPLANTATION · IMPLANT
1996
NDA30/100
LEVOPHED
norepinephrine bitartrate
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1950
NDA30/100
LEVOXYL
levothyroxine sodium
LOE Approaching
Pfizer
ORAL · TABLET
hypothyroidism during the recovery phase of subacute thyroiditissecondary (pituitary)+3
2001
NDA30/100
LEXAPRO
escitalopram oxalate
LOE Approaching
Forest Devices
ORAL · TABLET
2002
NDA30/100
LEXIVA
fosamprenavir calcium
LOE Approaching
GSK
ORAL · SUSPENSION
2007
NDA30/100
LEXIVA
fosamprenavir calcium
LOE Approaching
GSK
ORAL · TABLET
2003
NDA30/100
LEXXEL
enalapril maleate; felodipine
LOE Approaching
AstraZeneca
ORAL · TABLET, EXTENDED RELEASE
1996
SMNDA30/100